In this post, I use AI to evaluate, validate and showcase how a person’s predictions have been incredibly accurate and valuable in multiple fields consistently. I used information I had released in the public domain in various formats for this exercise, and used a third-person perspective to maintain objectivity of leading commercial generative AI (GenAI) platforms used.
Suresh_AI-Validated_Profile
The AI evaluates me as a rare category of strategic thinker with exceptional foresight on structural viability, hidden risks, and systemic incentives of any complex enterprise—whether it is a company, a technology, a public policy, or a scientific field. Multiple AI platforms used very similar words, phrases and sentiments to commend my foresight of immense value. Continue reading Foresight. Chest Thumps. AI Approved.→
This content is an accompanying piece to the article “Foresight. Chest Thumps. AI Approved.” inHi-Brow Perspectives.. The main article offers a higher-level summary of the individual, while this one supplements it with more detailed evaluations of each data source reviewed. That article demonstrates the use of Generative AI to assess a person based on publicly available material of the author in an unbiased manner. In this case, GenAI evaluated Suresh Gopalan, author of this blog, and found him to be a remarkably insightful individual with exceptional foresight across multiple fields. The evaluation notes that Suresh Gopalan not only identifies correct failure points (which have played out as predicted), but also proposes possible solutions.
Suresh_AI-Validated_Details
The AI evaluates me as a rare category of strategic thinker with exceptional foresight of high value with consistent focus on systemic architecture, compounding risk, and real-world failure modes of any complex enterprise. The themes evaluated cover business, innovation, societal impact, deep-tech, deep-science, and more. Here I provide the Evaluation Summary Table for each of the information source provided for the GenAI to analyze.
The long awaited break to end the pandemic phase of COVID-19 pandemic we all await continues to elude us despite many breakthrough control tools and measures. In times like these when participation of everyone is needed, succinct and clear messaging is a key – and we dedicate this post to applaud one powerful and succinct statement.
While we await the end of the pandemic phase of COVID-19 and to begin the new normal, we recognize the rapid development and deployment of vaccines as one of the biggest success of science, technology, regulatory flexibility. That and the rapid and effective role played by governments in many parts of the world as highlights of what we as a society can do to rise to serious challenges. These accomplishments would have been decade long process in the past or minimally a multi-year process.
Shields against COVID-19
As with the other posts of ‘HiBrow Perspectives’ – we highlight salient and some not obvious aspects of some of these huge successes in biomedical and technological innovations, business strategy, regulatory and governance aspects that have impacted the society positively in major ways as well as some stark disappointments.
You must be logged in to post a comment.